Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SEQUENT SCIENTIFIC Fact Sheet  (VITR)



Revealing on April 30: Are You Ready for the Upcoming Election Surprise?


Here is the latest financial fact sheet of SEQUENT SCIENTIFIC. For more details, see the SEQUENT SCIENTIFIC quarterly results and SEQUENT SCIENTIFIC share price. For a sector overview, read our pharmaceuticals sector report.

SEQUENT SCIENTIFIC Price History

Price Rs 124.7
Mkt Cap Rs m 31,098
Vol '000 76.9
P/E X -25.2
P/CF X -46.9
EPS (TTM) Rs -4.9
1 Day % -1.1
No. of shares m 249.48
1 Week % 4.4
1 Month % 9.8
1 Year % 64.6
52 week H/L Rs 155.5/70.2
As on Apr 25, 2024 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SEQUENT SCIENTIFIC Financials

No. of Mths
Year Ending
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
SEQUENT SCIENTIFIC EQUITY SHARE DATA
High Rs8999265336156 
Low Rs42527012162 
Sales per share (Unadj.) Rs42.147.554.856.957.0 
Earnings per share (Unadj.) Rs2.33.34.21.8-4.9 
Diluted earnings per shareRs2.33.34.21.8-4.9 
Cash flow per share (Unadj.) Rs4.05.36.23.9-2.7 
Dividends per share (Unadj.) Rs0.2000.5000 
Adj. dividends per shareRs0.200.000.500.000.00 
Avg Dividend yield %0.300.300 
Book value per share (Unadj.) Rs27.927.129.026.025.8 
Adj. book value per shareRs27.627.028.925.925.8 
Shares outstanding (eoy) m246.87248.37248.37248.37249.43 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x1.61.63.14.01.9 
Avg P/E ratio x28.522.939.8126.9-22.3 
P/CF ratio (eoy) x16.414.226.859.0-41.0 
Price / Book Value ratio x2.42.85.88.84.2 
Dividend payout %8.7011.900 
Avg Mkt Cap Rs m16,22618,79541,59056,80227,151 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,4591,6511,8722,3142,584 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
SEQUENT SCIENTIFIC INCOME DATA
Net Sales Rs m10,39311,79213,61614,12814,209 
Other income Rs m8710110510964 
Total revenues Rs m10,48011,89313,72114,23714,273 
Gross profit Rs m1,2491,7032,0111,094-528 
Depreciation Rs m419506506515557 
Interest Rs m328357244158355 
Profit before tax Rs m5899411,366529-1,377 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2012032282-157 
Profit after tax Rs m5698201,045448-1,220 
Gross profit margin %12.014.414.87.7-3.7 
Effective tax rate %3.412.823.615.411.4 
Net profit margin %5.57.07.73.2-8.6 
SEQUENT SCIENTIFIC BALANCE SHEET DATA
Current assets Rs m6,0617,2437,6678,0848,125 
Current liabilities Rs m4,4045,1495,1315,3745,588 
Net working cap to sales %15.917.818.619.217.9 
Current ratio x1.41.41.51.51.5 
Inventory Days Days9759312721 
Debtors Days Days9899938588 
Net fixed assets Rs m7,9607,3896,7636,7827,435 
Share capital Rs m494497497497499 
"Free" reserves Rs m6,3846,2336,7025,9535,926 
Net worth Rs m6,8786,7307,1996,4506,425 
Long term debt Rs m1,4781,5019371,2251,828 
Total assets Rs m14,02114,63214,43014,86615,661 
Interest coverage x2.83.66.64.4-2.9 
Debt to equity ratio x0.20.20.10.20.3 
Sales to assets ratio x0.70.80.91.00.9 
Return on assets %6.48.08.94.1-5.5 
Return on equity %8.312.214.56.9-19.0 
Return on capital %11.015.819.89.0-12.4 
Exports to sales %02.75.02.21.8 
Imports to sales %01.12.11.61.0 
Exports (fob) Rs m0316686311255 
Imports (cif) Rs m0130281220138 
Fx inflow Rs m0316686311255 
Fx outflow Rs m0130281220138 
Net fx Rs m018540591117 
SEQUENT SCIENTIFIC CASH FLOW
From Operations Rs m 1,160 1,153 1,148 306 168 
From Investments Rs m -677 -723 96 -956 -650 
From Financial Activity Rs m -201 -428 -1,388 673 322 
Net Cashflow Rs m 282 3 -144 38 -159 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 52.8%
Institution 13.8%
Non-Institution 33.5%
Total 100.0%
Free Float 47.2%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2024
 

Company Information

Regd Off 301 ' Dosti Pinnacle', 3rd Floor Plot No. E7, Road No. 22 Wagle Indl. Estate, Thane - 400604
E-mail investorrelations@sequent.in Web www.sequent.in
Tel 022 4111 4777 Fax 022 4111 4754
Sector PHARMACEUTICALS Group Sequent
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
CHM: Kamal K Sharma COMP SEC: Krunal Shah YEAR OF INC: 1985 BSE CODE: 512529 FV (Rs): 2 DIV YIELD (%): -

Read: SEQUENT SCIENTIFIC 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    CIPLA    ZYDUS LIFESCIENCES    SUN PHARMA    

Compare SEQUENT SCIENTIFIC With:   DIVIS LABORATORIES    DR. REDDYS LAB    CIPLA    ZYDUS LIFESCIENCES    SUN PHARMA    



 

Today's Market

Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5% Sensex Today Ends 487 Points Higher | Metal Stocks Shine | SBI & Axis Bank Zoom 5%(Closing)

After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.